Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,000
Closed -$697K 341
2023
Q3
$697K Sell
13,000
-17
-0.1% -$906 0.01% 186
2023
Q2
$702K Buy
13,017
+17
+0.1% +$915 0.02% 189
2023
Q1
$707K Hold
13,000
0.01% 183
2022
Q4
$630K Hold
13,000
0.01% 191
2022
Q3
$494K Hold
13,000
0.01% 209
2022
Q2
$650K Hold
13,000
0.01% 195
2022
Q1
$667K Hold
13,000
0.01% 209
2021
Q4
$651K Sell
13,000
-4,000
-24% -$198K 0.01% 219
2021
Q3
$820K Hold
17,000
0.02% 195
2021
Q2
$895K Hold
17,000
0.02% 191
2021
Q1
$841K Hold
17,000
0.02% 195
2020
Q4
$826K Hold
17,000
0.03% 193
2020
Q3
$853K Hold
17,000
0.03% 185
2020
Q2
$868K Hold
17,000
0.03% 176
2020
Q1
$743K Sell
17,000
-4,000
-19% -$191K 0.03% 166
2019
Q4
$1.05M Sell
21,000
-4,000
-16% -$187K 0.03% 165
2019
Q3
$1.16M Hold
25,000
0.03% 150
2019
Q2
$1.08M Hold
25,000
0.03% 162
2019
Q1
$1.11M Buy
+25,000
New +$1.07M 0.03% 161

Other funds holding SNY

Murray Stahl's SNY Position: Q4 2023 in Review

Murray Stahl sold out of Sanofi (SNY) in Q4 2023, closing a stake of 13,000 shares — an estimated $697K sold.

Murray Stahl first reported a position in SNY in Q1 2019 and held it in 19 quarters. The position peaked at $1.16M in Q3 2019. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • Murray Stahl reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
  • Murray Stahl sold 13,000 Sanofi shares in Q4 2023, an estimated $697K.
  • Murray Stahl first reported a position in Sanofi in Q1 2019 and held it in 19 quarters.
  • Murray Stahl's Sanofi position peaked at $1.16M in Q3 2019.
  • 709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.